FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, precision agriculture, and professional pest, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

FMC achieves record Q4 results, eyes growth amid cost challenges

FMC's strong Q4 performance and full-year results reflect growth across regions and product segments. While facing short-term challenges like cost pressures and supply disruptions, the company is poised for revenue and EBITDA growth in 2023. Strategic initiatives in sustainability, innovation, and market expansion position FMC for long-term success.

FMC reports solid Q1 earnings, focuses on growth and sustainability

FMC's Q1 performance was solid, driven by revenue growth and adjusted EBITDA increase, despite regional challenges.
The company's focus on new products, market access, and sustainability aligns with future growth strategies.
Challenges in Latin America and Asia require strategic management, while opportunities lie in cash flow growth and market expansion.
Overall, FMC's outlook remains positive with a commitment to innovation, sustainability, and financial resilience.

FMC reports Q2 sales decline, anticipates rebound in 2024

FMC faced challenges in Q2 with sales decline due to volume drop, impacting EBITDA and free cash flow guidance for 2023.
Despite challenges, the company is adapting by controlling costs, investing in R&D, and focusing on new product sales for long-term growth.
Opportunities lie in stabilizing inventory levels, focusing on R&D pipeline, and anticipating a rebound in cash flow as market conditions normalize.
FMC remains confident in managing through demand shocks, with a focus on customer intimacy, commercial operations, and market access for growth.

FMC reports Q3 revenue decline, eyes growth in 2024

FMC's Q3 performance saw revenue and EBITDA decline significantly, impacting free cash flow. Despite challenges in working capital and inventory levels, the company is focusing on growth strategies for its products. Opportunities lie in potential price increases, new product introductions, and positive sales growth projections for 2024.

FMC projects revenue growth in 2024 despite regional challenges

FMC faces challenges in certain regions but maintains a strong margin and optimistic revenue guidance for 2024, driven by new products.
The company's focus on operational efficiency through global restructuring and inventory management positions it for future growth.
Despite short-term adjustments, FMC's long-term targets remain intact, with expectations of accelerated growth in 2025.
Strong commercial performance with new products and strategic resilience in core businesses highlight FMC's potential for sustained growth.

FMC Corporation reports robust Q3 earnings, anticipates strong Q4 growth

FMC's Q3 performance showcased resilience and growth despite regional challenges. The company's focus on new product development and cost savings initiatives bodes well for future profitability. With strong Q4 projections, FMC is poised for continued success in the coming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

Investors need to pay close attention to FMC stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in FMC Stock?

Explore FMC's (FMC) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Don't Overlook FMC (FMC) International Revenue Trends While Assessing the Stock

PHILADELPHIA , Nov. 1, 2024 /PRNewswire/ -- FMC Corporation (NYSE:FMC) and Environmental Science U.S. LLC, known as Envu, today announced the successful completion of the sale of FMC's Global Specialty Solutions (GSS) business to Envu. The companies announced the signing of a definitive acquisition agreement on July 11, 2024, and have now satisfied all necessary conditions and regulatory approvals.

FMC Corporation and Envu complete the sale of FMC's Global Specialty Solutions business

FMC Corporation (NYSE:FMC ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Curt Brooks - Director, IR Pierre Brondeau - Chairman & CEO Andrew Sandifer - EVP and CFO Ronaldo Pereira - President Conference Call Participants Joel Jackson - BMO Capital Markets Aleksey Yefremov - KeyBanc Capital Markets Kevin McCarthy - VRP Steve Byrne - Bank of America Merrill Lynch Laurent Favre - BNP Paribas Josh Spector - UBS Chris Parkinson - Wolfe Research Vincent Andrews - Morgan Stanley Jeff Zekauskas - JPMorgan Laurence Alexander - Jefferies Patrick Cunningham - Citigroup Operator Good morning, and welcome to the Third Quarter 2024 Earnings Call for FMC Corporation. This event is being recorded [Operator Instructions].

FMC Corporation (FMC) Q3 2024 Earnings Call Transcript

FMC benefits from volume growth and lower costs from restructuring actions in the third quarter.

FMC's Earnings and Sales Surpass Estimates in Q3 on Higher Volumes

FMC (FMC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.44 per share a year ago.

FMC (FMC) Beats Q3 Earnings and Revenue Estimates

Volume growth and higher cost savings  led to earnings above  the  high end of guidance range Third Quarter 2024 Highlights Revenue of $1.07 billion, an increase of 9 percent versus Q3 2023 and up 12 percent organically1 Consolidated GAAP net income of $66 million, up $70 million from a net loss of $4 million in Q3 2023 Adjusted EBITDA of $201 million, up 15 percent versus Q3 2023 Consolidated GAAP net income of $0.52 per diluted share, up $0.55 from a net loss of $0.03 per diluted share in Q3 2023 Adjusted earnings per diluted share of $0.69, up 57 percent versus Q3 2023 GAAP Cash from operations of $160 million with free cash flow of $132 million Full-Year Outlook 2 Revenue outlook of $4.33 billion to $4.44 billion, reflecting a 2 percent decline at the midpoint versus 2023; reduced $20 million for loss of contribution from Global Specialty Solutions (GSS) business3 Adjusted EBITDA outlook range of $885 million to $915 million, reflecting an 8 percent decline at the midpoint versus 2023; reduced $10 million for loss of contribution from GSS business3 Adjusted earnings per diluted share outlook range of $3.16 to $3.52, reflecting a 12 percent decrease at the midpoint versus 2023 Increases target restructuring savings range to $125 million to $150 million of adjusted EBITDA net benefit Free cash flow outlook range unchanged at $400 million to $500 million PHILADELPHIA , Oct. 29, 2024 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today reported third quarter 2024 revenue of $1.07 billion, an increase of 9 percent versus third quarter 2023 and up 12 percent organically. On a GAAP basis, the company reported net income of $0.52 per diluted share in the third quarter, up from a net loss of $0.03 per diluted share in the third quarter 2023 driven by higher sales and lower costs from restructuring actions as well as a lower effective tax provision.

FMC Corporation reports strong growth in third quarter, confirms full-year outlook adjusted for expected sale of GSS business

Allstate

Advanced Micro Devices

Amazon

Amphenol

Dayforce Inc

DuPont de Nemours

First Solar

General Electric

Eli Lilly

Microsoft

Norwegian Cruise Line

Seagate Technology Holdings PLC

TransDigm

Uber

Zebra Technologies

BlackRock CEO Larry Fink says companies' earnings are “catching up” to high P/E ratios for their stocks. Here are 10 companies to keep an eye on.

Why these 17 stocks in the S&P 500 are now more compelling

Investors interested in Chemical - Diversified stocks are likely familiar with Johnson Matthey PLC (JMPLY) and FMC (FMC). But which of these two stocks offers value investors a better bang for their buck right now?

JMPLY or FMC: Which Is the Better Value Stock Right Now?

FMC is likely to have faced challenges from pricing pressure and significant unabsorbed fixed costs in the third quarter.

FMC to Report Q3 Earnings: What's in the Cards for the Stock?

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FMC (FMC) Reports Next Week: Wall Street Expects Earnings Growth

FMC benefits from its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.

FMC Stock Gains on New Products and Cost-reduction Actions

Cabot

DuPont de Nemours, FMC and Cabot have been highlighted in this Industry Outlook article.

Zacks Industry Outlook DuPont de Nemours, FMC and Cabot

Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, FMC and CBT are poised to navigate the industry challenges.

3 Diversified Chemical Stocks to Escape Industry Challenges

Middlefield Banc

MPLX

MPLX, FMC and MBCN made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 8, 2024.

Best Income Stocks to Buy for October 8th

Air Liquide SA

Investors looking for stocks in the Chemical - Diversified sector might want to consider either FMC (FMC) or Air Liquide (AIQUY). But which of these two stocks presents investors with the better value opportunity right now?

FMC vs. AIQUY: Which Stock Is the Better Value Option?

FMC gains on its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.

Here's Why You Should Add FMC Stock to Your Portfolio Now

FMC and Ballagro will be able to offer growers a full suite of biological solutions to boost productivity, efficiency and sustainability.

FMC Partners Ballagro to Expand Biologicals Crop Protection in Brazil

FMC Stock Rises 18% in 3 Months: What's Driving the Rally?

PHILADELPHIA , Sept. 30, 2024 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced an agreement with Ballagro Agro Tecnologia Ltda.

FMC Corporation announces distribution agreement with Ballagro Agro Tecnologia Ltda. to expand biologicals crop protection offering in Brazil

FMC, an agriscience company, faced revenue decline in 2023 due to industry destocking but is expected to recover as demand rebounds. Despite 2023 challenges, FMC has historically delivered returns exceeding its cost of funds, indicating strong shareholder value creation. It has also embarked on a cost reduction programme. With a conservative intrinsic value estimate showing a 27% margin of safety, FMC presents a compelling investment opportunity.

FMC: The Market Is Overreacting To The Industry's Destocking

PHILADELPHIA , Sept. 24, 2024 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, together with the UN Global Compact Network (UNGC) USA, convened global public and private sector leaders for a roundtable discussion on the future of sustainable food systems.

FMC Corporation and UN Global Compact Network USA convene global leaders to discuss future of sustainable food systems during United Nations General Assembly

FMC Corporation stock (NYSE: FMC), an agricultural science company focused on products to improve crop yield and quality, currently trades around $64 per share, roughly 51% below its pre-inflation shock highs of around $131 seen in April 2022. FMC has fared much worse than its peer – CF Industries stock (NYSE: CF) – down 10% over this period.

What's Happening With FMC Stock?

PHILADELPHIA , Sept. 19, 2024  /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its third quarter 2024 earnings on Tuesday, October 29, 2024, after the stock market close via PR Newswire and the company's website https://investors.fmc.com.

FMC Corporation announces dates for third quarter 2024 earnings release and webcast conference call

While FMC faces headwinds from pricing and cost pressures, it gains on its efforts to strengthen its product portfolio and restructuring actions.

News for FMC Stock (FMC)